You are here

A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Albany Advanced Imaging
Albany, New York, 12205 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Multiple Sclerosis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Women and men aged 18-55 yrs.

- Confirmed diagnosis of Multiple Sclerosis (MS) according to the 2010 revision of the
McDonald Criteria.

- Expanded Disability Status Scale (EDSS) between 0-5, inclusive.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Relapse episode of MS within 2 weeks of enrollment.

- Primary progressive MS without a relapsing component.

- Intolerant or unwilling to undergo MRI scanning. Treatment with disease modifying
agents up to 6 weeks prior to enrollment.

NCT02045732
Pfizer
Terminated
A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Secondary Progressive Multiple Sclerosis
NCT00146159
All Genders
18+
Years
Multiple Sites
Relapsing-Remitting Multiple Sclerosis
NCT00228397
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now